BioSpace News Archive

Business

ORYZON First Half Ended June 30, 2020 Results and Corporate Update

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the first half of 2020 and provided an update on recent developments.

July 22, 2020
·
8 min read
Biotech Beach

Seragon Pharmaceuticals announces GenomeScore™, an AI platform to predict speed of aging and physiological changes

Seragon Pharmaceuticals, Inc., a southern California biopharmaceutical company, announces GenomeScore™ platform, a neural network-trained algorithm combining epigenetic and transcriptome analysis to predict individuals’ aging speed and assessing aspects of physiological functions.

July 22, 2020
·
3 min read
Business

Zero Gravity Solutions and its Subsidiary, BAM Agricultural Solutions Appoints Victor Robenson as Vice President of Business Development, Marketing and Sales

Zero Gravity Solutions, Inc. (“ZGSI” or the “Company”) (Pink Sheets: ZGSI), an agricultural biotechnology company, has appointed Victor Robenson as Vice President of Business Development, Marketing and Sales.

July 22, 2020
·
3 min read
Business

Ladan Eshkevari Honored as 2020 Star Nurse by The Washington Post

— The Washington Post recently selected Ladan Eshkevari, PhD, CRNA, LAc., FAAN, as a 2020 Star NurseTM. Eshkevari, a member of the American Association of Nurse Anesthetists, is an associate professor at the Georgetown University Medical Center’s School of Nursing & Health Studies in Washington, DC.

July 22, 2020
·
2 min read
Data Shows Direct Link Between COVID-19 and Acute Respiratory Distress Syndrome (ARDS) In Infected Patients

There is a direct link between the COVID-19 virus and acute respiratory distress syndrome (ARDS) in COVID-19 patients.

July 22, 2020
·
10 min read
Business

Taro to Announce First Quarter Results on July 29, 2020

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2020, after the close of market on Wednesday, July 29, 2020.

July 22, 2020
·
1 min read
Pharm Country

New COVID-19 Projections Show Risk for Resurgence Continues Spread to Northeast

Updated COVID-19 projections released by PolicyLab at Children’s Hospital of Philadelphia show communities across the Northeast are struggling to fend off risk for virus resurgence as the south continues to experience significant growth in cases.

July 22, 2020
·
4 min read
Biotech Bay

Syapse Highlights Real-World Evidence Related to COVID-19 and Cancer at AACR Virtual Meeting

Syapse®, a real-world data company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, announced results based on real-world data that were highlighted at the AACR Virtual Meeting on COVID-19 and Cancer.

July 22, 2020
·
4 min read
Genetown

Entera Bio Ltd. Announces Highly Encouraging Oral PTH Market Survey Results

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced today the results from two primary market research studies of clinicians who treat osteoporosis patients.

July 22, 2020
·
9 min read
Business

SeaSpine to Report Second Quarter 2020 Financial Results on August 4, 2020

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading on Tuesday, August 4, 2020.

July 22, 2020
·
1 min read